Cover Image

Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis

Saved in:

Bibliographic Details
Main Authors:	Ilaria De Benedetto (Author), Lucio Boglione (Author), Elena Salvador (Author), Tommaso Lupia (Author), Amedeo De Nicolò (Author), Giovanni Di Perri (Author), Filippo Lipani (Author), Anna M. Lucchini (Author)
Format:	Book
Published:	Elsevier, 2020-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Visceral leishmaniasis in a patient with active HBV/HDV co-infection
by: Tommaso Lupia, et al.
Published: (2020)

The Levels of Ghrelin, Leptin, TNF-α, and IL-6 in Liver Cirrhosis and Hepatocellular Carcinoma due to HBV and HDV Infection
by: Huseyin Ataseven, et al.
Published: (2006)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Yan Huang, et al.
Published: (2022)

Immunological response of Hepatitis B Virus Surface Antigen in HBV Mono and HBV/HDV Co-infection
by: Mehwish Sajjad, et al.
Published: (2024)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
by: Yang YM, et al.
Published: (2017)

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective
by: Tsai N, et al.
Published: (2012)

HBV-Associated Cryoglobulinemic Vasculitis: Remission after Antiviral Therapy with Entecavir
by: Mauro Viganò, et al.
Published: (2014)

Induced Rhabdomyolysis Associated With Decompensated Cirrhosis
by: William Dungan MD, et al.
Published: (2022)

Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir
by: Jessica Cusato, et al.
Published: (2015)

Buschke-Lowenstein tumor in a patient with decompensated cirrhosis
by: F. N. U. Shailesh, et al.
Published: (2014)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
by: Manasa Kandula, et al.
Published: (2016)

Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial
by: Yufeng Xing, et al.
Published: (2023)

Sarcopenia and frailty combined increases the risk of mortality in patients with decompensated cirrhosis
by: Gaoyue Guo, et al.
Published: (2022)

Analysis of hope level and its influencing factors in patients with decompensated cirrhosis
by: Yuanyuan Zhang, et al.
Published: (2023)

Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
by: Kelly L. Hayward, et al.
Published: (2021)

Underestimated Prevalence of HIV, Hepatitis B Virus (HBV), and Hepatitis D Virus (HDV) Triple Infection Globally: Systematic Review and Meta-analysis
by: Sisi Chen, et al.
Published: (2022)

Characteristic of renal response to the salt-loading test in patients with decompensated liver cirrhosis
by: O. B. Kvasnytska, et al.
Published: (2018)

Characteristic of renal response to the salt-loading test in patients with decompensated liver cirrhosis
by: O. B. Kvasnytska, et al.
Published: (2018)

Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings
by: Irsan Hasan, et al.
Published: (2024)

Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy
by: Annie S. Hong, et al.
Published: (2022)

Association between serum trace elements and sleep disturbance in patients with decompensated cirrhosis
by: Ziyue Zhang, et al.
Published: (2023)

The characteristic of a splanchnic blood-groove at patients with the compensated and decompensated course of cirrhosis
by: A. S. Tugushev, et al.
Published: (2015)

Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis
by: Da Zhou, et al.
Published: (2023)

A bite difficult to heal: Pasteurella multocida induced decompensated hepatic cirrhosis
by: Hiren Patel, et al.
Published: (2021)

The Role of Clinical Pharmacist in Reducing Drug Related Problems in Decompensated Liver cirrhosis patients
by: Ameer Alobeidi, et al.
Published: (2023)

Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy
by: Judith N. Torimiro, et al.
Published: (2018)

Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study
by: Yu-Han Huang, et al.
Published: (2023)

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
by: Fei-lin Ge, et al.
Published: (2021)

HDV/AIDS awareness among young people and their sexual behaviour
by: A. A. Khryanin, et al.
Published: (2019)

Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan
by: Fuu-Jen Tsai, et al.
Published: (2020)

Association of Systemic Inflammation Response Index with Short-Term All-Cause Mortality in Decompensated Liver Cirrhosis Patients
by: Cheng J, et al.
Published: (2024)

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy
by: Jessica Cusato, et al.
Published: (2022)

A changing landscape: Tracking and analysis of the international HDV epidemiology 1999-2020.
by: Braden S Fallon, et al.
Published: (2023)

A changing landscape: Tracking and analysis of the international HDV epidemiology 1999-2020
by: Braden S. Fallon, et al.
Published: (2023)

Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
by: He-Yun Cheng, et al.
Published: (2022)

Urinary albumin-to-creatinine ratio in decompensated liver cirrhosis among elderly Egyptian patients: a single-center experience
by: Ahmed Abdelghani, et al.
Published: (2021)

Cortical Signature of Patients with HBV-related Cirrhosis without Overt Hepatic Encephalopathy: a Morphometric Analysis
by: Xiu eWu, et al.
Published: (2015)

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status
by: Zhujun Cao, et al.
Published: (2022)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
by: Xiao-Jie Lu, et al.
Published: (2020)

Low rates of screening and treatment of chronic hepatitis B, C, D (HBV, HCV, HDV), and hepatocellular carcinoma (HCC), associated barriers, and proposed solutions: results of a survey of physicians from all major provinces of Mongolia
by: J. Estevez, et al.
Published: (2016)